UKAD 2023 UKAD vs Robert Helenius

In September 2023 United Kingdom Anti-Doping (UKAD) reported an anti-doping rule violation against the Finnish boxer Robert Helenius after his sample tested positive for the prohibited substance Clomifene. Following notification a provisional suspension was ordered and the Athelte filed a statement in his defence.

The Athlete admitted the violation and denied the intentional use of the substance. He assumed that the Clomifene entered his system through the consumption of eggs and chicken meat in his diet.

UKAD accepted that the the Athlete's violation was not intentional. However UKAD deemed that he failed to demonstrate with any corroborating evidence that eggs and chicken meat in question were the source of the prohibited substance.

Therefore UKAD decides on 27 June 2024 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 18 September 2023.

Original document

Parameters

Legal Source
National Decisions
Date
27 June 2024
Original Source
UK Anti-Doping (UKAD)
Country
Finland
United Kingdom
Language
English
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Burdens and standards of proof
Circumstantial evidence
No intention to enhance performance
Period of ineligibility
Sport/IFs
Boxing (IBA) - International Boxing Association
Other organisations
UK Anti-Doping (UKAD)
Laboratories
London, United Kingdom: Drug Control Centre
Doping classes
S4. Hormone And Metabolic Modulators
Substances
Clomifene
Various
Contamination
Food and/or drinks
Document type
Pdf file
Date generated
22 July 2024
Date of last modification
23 July 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin